Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Exelixis Inc (EXEL)

20.71 -0.12 (-0.58%)

04-26 16:00

Open:

20.86

Pre. Close:

20.83

High:

21.24

Low:

20.625

Volume:

1,848,149

Market Cap:

6144M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

21.3 - 21.418

21.418 - 21.514

Low:

20.266 - 20.433

20.433 - 20.568

Close:

20.466 - 20.712

20.712 - 20.912

Technical analysis  (as of: 2018-04-26 4:29:45 PM)

Overall:

      

Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.

Target:

Six months: 26.18     One year: 28.22

Support:

Support1: 19.60    Support2: 16.31

Resistance:

Resistance1: 22.42    Resistance2: 24.16

Pivot:

20.80

Moving Averages:

MA(5): 20.71     MA(20): 21.06

MA(100): 26.40     MA(250): 25.47

MACD:

MACD(12,26): -0.84     Signal(12,26,9): -1.01

%K %D:

%K(14,3): 36.89     %D(3): 34.73

RSI:

RSI(14): 40.74

52-Week:

High: 32.5  Low: 18.03  Change(%): -7.5

Average Vol(K):

3-Month: 305096  10-Days 231201

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
EXEL has closed above bottom band by 45.4%. Bollinger Bands are 58.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to EXEL's normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-04-26T08:00:00-04:00
Cabozantinib to Be Featured in 15 Presentations at ASCO 2018 Annual Meeting

2018-04-24T11:01:46-04:00
Bristol-Myers And Exelixis Poise For Battle In Kidney Cancer - Who Will Emerge The Victor?

2018-04-24T07:42:02-04:00
Interest Rates Will Not Hurt Stocks As Much As Trade War - Cramer's Mad Money (4/23/18)

2018-04-24T01:42:47-04:00
JF's Core Biotech Buys #12: Updates And Introducing Our 18th Selection

2018-04-20T08:00:00-04:00
3 Things In Biotech, April 19: Let's Talk Genito-Urinary Cancer

2018-04-20T07:18:22-04:00
Why Investment Wealth-Builders Disdain Big Pharma Stocks Now

2018-04-18T07:16:45-04:00
Calithera's CB-839 Fast Track'd for advanced kidney cancer

2018-04-17T11:46:21-04:00
JF's Core Biotech Buys #11: Positive News For Several Holdings, A Change To Benchmarks And Introducing Our 17th Position

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

296.66

Shares Float (M)

291.78

% Held by Insiders

1.60

% Held by Institutions

89.70

Shares Short (K)

12463

Shares Short Prior Month (K)

19880

Stock Financials

EPS

0.510

EPS Est. Current Year

0.280

EPS Est. Next Year

0.670

EPS Est. Next Quarter

0.090

Forward EPS

1.280

Book Value (p.s.)

21.960

PEG Ratio

0.80

Profit Margin

49.09

Operating Margin

36.90

Return on Assets (ttm)

24.6

Return on Equity (ttm)

82.2

Qtrly Rev. Growth

54.8

Gross Profit (p.s.)

1.084

Sales Per Share

EBITDA (p.s.)

0.435

Qtrly Earnings Growth

9.60

Operating Cash Flow (M)

165.61

Levered Free Cash Flow (M)

90.70

atoplab.com

Valuation

P/E

40.61

P/E Growth Ratio

-0.01

P/BV

0.94

P/S

3989498880.00

P/CF

37.10

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.